Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Healthcare
Create a narrative
CellaVision Community
OM:CEVI Community
1
Narratives
written by author
0
Comments
on narratives written by author
14
Fair Values set
on narratives written by author
Create a narrative
CellaVision
Popular
Undervalued
Overvalued
Community Investing Ideas
CellaVision
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
R&D And FPM Products Will Expand EMEA Collaborations
Key Takeaways Strategic R&D investments and next-gen products could enhance offerings and capture greater market share, potentially boosting revenue and competitiveness. Strong financial position and partnerships, especially in EMEA, support sales growth and expansion, promising improved profitability and sustained growth.
View narrative
SEK 232.00
FV
20.2% undervalued
intrinsic discount
11.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
CEVI
CEVI
CellaVision
Your Fair Value
SEK
Current Price
SEK 185.20
21.7% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
1b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 1.3b
Earnings SEK 256.3m
Advanced
Set Fair Value